Phoenix criteria for biochemical failure
Webb30 okt. 2010 · Median follow-up was 15.4 years for patients who were biochemically free of disease. Median overall follow-up was 11.7 years (range, 3.6 to 18.4 years). ... using the … WebbThe bRFS was defined as the time between the end of reirradiation and the biochemical progression. Patients without biochemical recurrence are those with a PSA response or a stable PSA (PSA between minus 30% compared to pre-irradiation PSA level or plus 50% compared to post-therapeutic nadir).
Phoenix criteria for biochemical failure
Did you know?
WebbFor biochemical failure (BF), both the American Society for Therapeutic Radiology and Oncology (ASTRO) (BF-ASTRO) 10 and Phoenix (BF-Phoenix) 11 definitions of PSA … Webb1 jan. 2008 · The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. The Phoenix definition of BF is a more robust determinant …
Webb9 sep. 2004 · The Phoenix criteria for biochemical failure is a rise of 2 ng/mL or more above the nadir after radiation therapy. Time to failure is defined as time from registration to the date of first failure, last known follow-up (censored), or death without failure (competing risk). Failure rate is estimated using the cumulative incidence method. Webb8 maj 2012 · The objective of this study was to evaluate and compare biochemical failure free survival (BFFS) after low-dose-rate brachytherapy (LDRB) alone for patients with prostate cancer using ASTRO and Phoenix criteria, and detect prognostic factors. Methods Data on 220 patients treated between 1998 and 2002 with LDRB were retrospectively …
WebbEarly results have previously described a comparable toxicity profile as measured by quality of life outcomes. Materials/Methods: From September 2011 to August 2024, 21 … WebbUsing the Phoenix criteria for biochemical failure, HIFU failed in 26.6% during a mean followup of 29.9 months (median 15 months, range 9–40 months). Stratification of failure by D’Amico criteria [6]wasout of the 16 failures, 43.7% high-risk, 12.5% intermediate-risk, 43.7% low-risk. In the high risk group, failures were 87.5%,
WebbBiochemical Failure (American Society for Therapeutic Radiology and Oncology [ASTRO] Consensus Definition and Phoenix Criteria) After Either Conventional-Dose (70.2 Gy) or High-Dose (79.2 Gy) Radiation Therapy View LargeDownload HR indicates hazard ratio. Table 1. Pretreatment Characteristics View LargeDownload Table 2.
Webb1 feb. 2011 · Absolute rate of disease free survival at 2 years, the primary study endpoint, was significantly improved (84%) when compared with a rate of 64% for similar patients … designed by gg ironclad v2 redWebb1 juli 2024 · The biochemical failure based on Phoenix criteria was associated with quantitative MRI values. A two-tailed t-test was performed to assess the differences between the quantitative mpMRI parameters between the two groups: patients with biochemical failure and those who were biochemically controlled. chubby candy barWebb12 maj 2024 · 2 years and then every 6 months until biochemical failure occurred or until the last control. Biochemical failure was defined as an increase of more than 2 ng/ml above the nadir level of serum PSA obtained after completing EBRT according to the ‘Phoenix’ criteria of ASTRA II [8]. Detection of minimal residual disease designed by lbj in californiaWebb13 apr. 2024 · Date palm (Phoenix dactylifera L.) is a considerably beneficial and economically profitable fruit crop. Female date palm plants produce fruit that is rich in … designed by good peopleWebbProgrès récents xiii. Medicinal plants of the arid zones Les plantes médicinales des régions arides XIV. Salinity problems in the arid zones. Proceedings of the Teheran Symposium Les problèmes de la salinité dans les régions arides. Actes du colloque de Téhéran xv . Plant-water relationships in arid and semi-arid conditions. chubby candy caloriesWebbto biochemical recurrence based on initial risk category. For the men that failed a second brachytherapy procedure, the median time to failure was months, with a range of to … designed by macrovector / freepikWebb22 dec. 2024 · Focal boosting up to 95 Gy in the FLAME trial improved rates of local failure and of regional + distant metastatic failure (rdMF) for patients with localized, mainly high-risk prostate cancer. Dose-response analyses showed the beneficial effect of higher doses to the tumor on rdMF and local failure, even when the boost dose of 95 Gy cannot be … chubby carmichael